Literature DB >> 10818429

Idiopathic juvenile osteoporosis.

G E Krassas1.   

Abstract

Osteoporosis in childhood is uncommon, and it may be secondary to a spectrum of diverse conditions. When such causes have been excluded, some patients remain who have a congenital disease (osteoporosis imperfecta) or a disease in which the etiology is obscure, called idiopathic juvenile osteoporosis (IJO). The cause of IJO is unknown, and the diagnosis is based both on the exclusion of other diseases and on its own positive fractures. The basic strategy of treatment is to protect the spine until remission occurs. Sex steroids are contraindicated. Bisphosphonates, calcitriol, fluoride, and calcitonin have been administered therapeuticlly, but the results were equivocal. Usually the disease remits by itself.

Entities:  

Mesh:

Year:  2000        PMID: 10818429     DOI: 10.1111/j.1749-6632.2000.tb06253.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  12 in total

1.  Bone density assessment in patients with mucopolysaccharidosis: A preliminary report from patients with MPS II and VI.

Authors:  Ellen B Fung; Jo Ann Johnson; Jacqueline Madden; Tiffany Kim; Paul Harmatz
Journal:  J Pediatr Rehabil Med       Date:  2010

Review 2.  Bone mineral accrual and low bone mass: a pediatric perspective.

Authors:  Inessa M Gelfand; Linda A DiMeglio
Journal:  Rev Endocr Metab Disord       Date:  2005-12       Impact factor: 6.514

3.  Pamidronate treatment stimulates the onset of recovery phase reducing fracture rate and skeletal deformities in patients with idiopathic juvenile osteoporosis: comparison with untreated patients.

Authors:  Giampiero I Baroncelli; Francesco Vierucci; Silvano Bertelloni; Paola Erba; Elisa Zampollo; Maria Rita Giuca
Journal:  J Bone Miner Metab       Date:  2013-04-03       Impact factor: 2.626

Review 4.  Osteoporosis in children and adolescents: etiology and management.

Authors:  Giampiero Igli Baroncelli; Silvano Bertelloni; Federica Sodini; Giuseppe Saggese
Journal:  Paediatr Drugs       Date:  2005       Impact factor: 3.022

5.  Effective parenteral clodronate treatment of a child with severe juvenile idiopathic osteoporosis.

Authors:  Ralph Melchior; Bernard Zabel; Jürgen Spranger; Roland Schumacher
Journal:  Eur J Pediatr       Date:  2004-10-23       Impact factor: 3.183

Review 6.  Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients.

Authors:  Stefania Costi; Teresa Giani; Francesco Orsini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2022-01-11       Impact factor: 3.022

7.  Primary osteoporosis in children.

Authors:  Lay Ong Tan; Soo Yen Lim; Rashida Farhad Vasanwala
Journal:  BMJ Case Rep       Date:  2017-09-01

Review 8.  Rare causes of osteoporosis.

Authors:  Gemma Marcucci; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2015-10-26

9.  Juvenile osteoporosis in a 5-year-old girl.

Authors:  Saket R Sanghai; Ira Shah
Journal:  J Nat Sci Biol Med       Date:  2013-07

10.  Idiopathic juvenile osteoporosis: A case report and review of the literature.

Authors:  Ahmet Imerci; Umut Canbek; Sema Haghari; Levent Sürer; Muge Kocak
Journal:  Int J Surg Case Rep       Date:  2015-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.